Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients

BJU International

Volumn 107, Issue 11, 2011, Pages 1775-1779

  Van Roermund, Joep G H ^a,c   Hinnen, Karel A ^a   Tolman, Christine J ^a   Bol, Gijsbert H ^a   Witjes, J Alfred ^b   Bosch, J L H Ruud ^a   Kiemeney, Lambertus A ^b   Van Vulpen, Marco ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

Author keywords

Body Mass Index (BMI); obesity; prostate cancer; radiotherapy; visceral fat

Indexed keywords

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY MASS; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; GLEASON SCORE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PERIPROSTATIC FAT; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT;

ADIPOSE TISSUE; AGED; BODY FAT DISTRIBUTION; BODY MASS INDEX; BRACHYTHERAPY; COHORT STUDIES; DISEASE PROGRESSION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NETHERLANDS; ODDS RATIO; PROGNOSIS; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78650499168     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09811.x     Document Type: Article

References (30)

1. Quinn M, Babb P,. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int 2002; 90: 162-73 (Pubitemid 34779587)
2. Kamangar F, Dores GM, Anderson WF,. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 2137-50 (Pubitemid 46655601)
3. Amling CL, Riffenburgh RH, Sun L, et al,. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 2004; 22: 439-45 (Pubitemid 41079772)
4. Freedland SJ, Aronson WJ, Kane CJ, et al,. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 2004; 22: 446-53 (Pubitemid 41079773)
5. Rodriguez C, Freedland SJ, Deka A, et al,. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 2007; 16: 63-9 (Pubitemid 46174265)
6. van Roermund JG, Kok DE, Wildhagen MF, et al,. Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy. BJU Int 2009; 104: 321-5
7. van Roermund JG, Hinnen KA, Battermann JJ, et al,. Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapy. BJU Int 2009; 105: 42-8
8. Gallina A, Karakiewicz PI, Hutterer GC, et al,. Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men. Int J Cancer 2007; 121: 791-5 (Pubitemid 47106208)
9. Dusserre E, Moulin P, Vidal H,. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 2000; 1500: 88-96 (Pubitemid 29525402)
10. von Hafe P, Pina F, Perez A, Tavares M, Barros H,. Visceral fat accumulation as a risk factor for prostate cancer. Obes Res 2004; 12: 1930-5
11. Battermann JJ, Boon TA, Moerland MA,. Results of permanent prostate brachytherapy, 13 years of experience at a single institution. Radiother Oncol 2004; 71: 23-8 (Pubitemid 38452898)
12. Dehnad H, Nederveen AJ, van der Heide UA, van Moorselaar RJ, Hofman P, Lagendijk JJ,. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol 2003; 67: 295-302 (Pubitemid 36831082)
13. Ash D, Flynn A, Battermann J, de nnnnnn RT, Lavagnini P, Blank L,. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 2000; 57: 315-21
14. Bol GH, Kotte AN, van der Heide UA, Lagendijk JJ,. Simultaneous multi-modality ROI delineation in clinical practice. Comput Methods Programs Biomed 2009; 96: 133-40
15. Yoshizumi T, Nakamura T, Yamane M, et al,. Abdominal fat: standardized technique for measurement at CT. Radiology 1999; 211: 283-6 (Pubitemid 29161765)
16. Bassett WW, Cooperberg MR, Sadetsky N, et al,. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology 2005; 66: 1060-5 (Pubitemid 41587161)
17. Jayachandran J, Banez LL, Aronson WJ, et al,. Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Cancer 2009; 115: 5263-71
18. Palma D, Pickles T, Tyldesley S,. Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer. BJU Int 2007; 100: 315-9 (Pubitemid 47036558)
19. Strom SS, Kamat AM, Gruschkus SK, et al,. Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer 2006; 107: 631-9 (Pubitemid 44107225)
20. Paaskesen CE, Borre M,. Body mass index and prognostic markers at radical prostatectomy. Scand J Urol Nephrol 2008; 42: 230-6 (Pubitemid 351574395)
21. Pfitzenmaier J, Pritsch M, Haferkamp A, et al,. Is the body mass index a predictor of adverse outcome in prostate cancer after radical prostatectomy in a mid-European study population? BJU Int 2009; 103: 877-82
22. Gast GC, Frenken FJ, van Leest LA, Wendel-Vos GC, Bemelmans WJ,. Intra-national variation in trends in overweight and leisure time physical activities in The Netherlands since 1980: stratification according to sex, age and urbanisation degree. Int J Obes (Lond) 2007; 31: 515-20
23. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM,. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-55
24. Peytremann-Bridevaux I, Faeh D, Santos-Eggimann B,. Prevalence of overweight and obesity in rural and urban settings of 10 European countries. Prev Med 2007; 44: 442-6 (Pubitemid 46686688)
25. Pischon T, Boeing H, Weikert S, et al,. Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2008; 17: 3252-61
26. Griffin CR, Yu X, Desireddi VN, et al,. Pathological features after radical prostatectomy in potential candidates for active monitoring. J Urol 2007; 178: 860-3 (Pubitemid 47224947)
27. Nguyen CT, Reuther AM, Stephenson AJ, Klein EA, Jones JS,. The Specific Definition of High Risk Prostate Cancer Has Minimal Impact on Biochemical Relapse-Free Survival. J Urol 2009; 181: 75-80
28. D'Amico AV, Whittington R, Malkowicz SB, et al,. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-74 (Pubitemid 28445094)
29. Powell K,. Obesity: the two faces of fat. Nature 2007; 447: 525-7 (Pubitemid 46868025)
30. Finley DS, Calvert VS, Inokuchi J, et al,. Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness. J Urol 2009; 182: 1921-7